ENTX - Company ID 0001638097
The table below shows Entera Bio Ltd.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $42.00K | $181.00K | $0.00 | $134.00K | $571.00K | $365.00K |
| Cost of revenue | $42.00K | $172.00K | $0.00 | $101.00K | $373.00K | $300.00K |
| Gross profit | $0.00 | $9.00K | $0.00 | $33.00K | $198.00K | $65.00K |
| R&D | $6.00M | $4.50M | $4.51M | $5.85M | $6.77M | $6.38M |
Entera Bio Ltd. reported annual revenue of $42.00K for fiscal year 2025. That is down 76.8% from $181.00K in fiscal 2024. Over the 6 fiscal years shown, annual revenue declined from $365.00K (FY 2020) to $42.00K. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $398.00K |
| $340.00K |
| $4.43M |
| $7.25M |
| $5.69M |
| $4.85M |
| Operating income | -$11.53M | -$9.59M | -$8.89M | -$13.02M | -$12.22M | -$11.17M |
| Income tax | $0.00 | $14.00K | $29.00K | $137.00K | -$59.00K | $20.00K |
| Net income | -$11.44M | -$9.54M | -$8.89M | -$13.07M | -$12.19M | -$11.22M |
| EPS (diluted) | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 | - |